Mortality in Sickle Cell Anemia in Africa: A Prospective Cohort Study in Tanzania
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The World Health Organization has declared Sickle Cell Anemia (SCA) a public health priority. There are 300,000 births/year, over 75% in Africa, with estimates suggesting that 6 million Africans will be living with SCA if average survival reaches half the African norm. Countries such as United States of America and United Kingdom have reduced SCA mortality from 3 to 0.13 per 100 person years of observation (PYO), with interventions such as newborn screening, prevention of infections and comprehensive care, but implementation of interventions in African countries has been hindered by lack of locally appropriate information. The objective of this study was to determine the incidence and factors associated with death from SCA in Dar-es-Salaam. METHODS AND FINDINGS: A hospital-based cohort study was conducted, with prospective surveillance of 1,725 SCA patients recruited from 2004 to 2009, with 209 (12%) lost to follow up, while 86 died. The mortality rate was 1.9 (95%CI 1.5, 2.9) per 100 PYO, highest under 5-years old [7.3 (4.8-11.0)], adjusting for dates of birth and study enrollment. Independent risk factors, at enrollment to the cohort, predicting death were low hemoglobin (<5 g/dL) [3.8 (1.8-8.2); p = 0.001] and high total bilirubin (≥102 µmol/L) [1.7 (1.0-2.9); p = 0.044] as determined by logistic regression. CONCLUSIONS: Mortality in SCA in Africa is high, with the most vulnerable period being under 5-years old. This is most likely an underestimate, as this was a hospital cohort and may not have captured SCA individuals with severe disease who died in early childhood, those with mild disease who are undiagnosed or do not utilize services at health facilities. Prompt and effective treatment for anemia in SCA is recommended as it is likely to improve survival. Further research is required to determine the etiology, pathophysiology and the most appropriate strategies for management of anemia in SCA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320 · cited 5×
“13 per 100 PYO reported from the USA[4,6].”
BackgroundMethodResultInfluentialGlobal epidemiology of haemoglobin disorders and derived service indicators
Modell, B. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.06.036673 · Cited by 1,924
Prophylaxis with Oral Penicillin in Children with Sickle Cell Anemia
Gaston, M. H., Verter, J. I., Woods, G., Pegelow, C., Kelleher, J., Presbury, G., Zarkowsky, H., Vichinsky, E., Iyer, R., Lobel, J. S., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606193142501 · Cited by 1,162
Disease Control Priorities in Developing Countries (2nd Edition)
Bank, W. (2006) · World Bank, Washington, DC eBooks · doi:10.1596/978-0-8213-6179-5 · Cited by 987
March of Dimes: global report on birth defects, the hidden toll of dying and disabled children.
Christianson, A. L., Howson, C. P., & Modell, B. (2005) · UCL Discovery (University College London) · Cited by 985
Steinberg, M. H., Barton, F., Castro, O., Pegelow, C. H., Ballas, S. K., Kutlar, A., Orringer, E., Bellevue, R., Olivieri, N., Eckman, J., et al. (2003) · JAMA · doi:10.1001/jama.289.13.1645 · Cited by 931
Kato, G. J., McGowan, V., Machado, R. F., Little, J. A., Taylor, J., Morris, C. R., Nichols, J. S., Wang, X., Poljakovic, M., Morris, S. M., et al. (2006) · Blood · doi:10.1182/blood-2005-06-2373 · Cited by 661 · cited 3×
“Furthermore, most of the studies that have shown this association were in adults[5]; the most recent study by Taylor et al, examined SCA patients over 30 years[32].”
BackgroundMethodInfluentialGill, F., Sleeper, L., Weiner, S., Brown, A., Bellevue, R., Grover, R., Pegelow, C., & Vichinsky, E. (1995) · Blood · doi:10.1182/blood.v86.2.776.bloodjournal862776 · Cited by 518
Mortality in Sickle Cell Disease
(1994) · New England Journal of Medicine · doi:10.1056/nejm199410133311515 · Cited by 459
Survival of children with sickle cell disease
Quinn, C. T., Rogers, Z. R., & Buchanan, G. R. (2004) · Blood · doi:10.1182/blood-2003-11-3758 · Cited by 377
Cited by
Grosse, S. D., Odame, I., Atrash, H. K., Amendah, D. D., Piel, F. B., & Williams, T. N. (2011) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2011.09.013 · Cited by 707
Self-citationSickle Cell Disease—Genetics, Pathophysiology, Clinical Presentation and Treatment
Inusa, B., Hsu, L., Kohli, N., Patel, A., Ominu-Evbota, K., Anie, K., & Atoyebi, W. (2019) · International Journal of Neonatal Screening · doi:10.3390/ijns5020020 · Cited by 313
Physiology and pathophysiology of iron in hemoglobin-associated diseases
Coates, T. D. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.03.039 · Cited by 181
Mmbando, B. P., Mgaya, J., Cox, S. E., Mtatiro, S. N., Soka, D., Rwezaula, S., Meda, E., Msaki, E., Snow, R. W., Jeffries, N., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0125929 · Cited by 23
“The study included individuals seen at MNH between March 2004 and December 2013 within the framework of the Muhimbili Sickle Cell (MSC) programme which has been previously described [3,14].”
MethodSelf-citationFetal hemoglobin is associated with peripheral oxygen saturation in sickle cell disease in Tanzania
Nkya, S., Mgaya, J., Urio, F., Makubi, A., Thein, S. L., Menzel, S., Cox, S. E., Newton, C. R., Kirkham, F. J., Mmbando, B. P., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.08.006 · Cited by 13
“Recruitment and enrolment of patients and diagnosis of SCD has been previously described (Makani et al., 2011).”
BackgroundSelf-citation
Metadata
- Authors
- Makani, J., Cox, S. E., Soka, D., Komba, A. N., Oruo, J., Mwamtemi, H., Magesa, P., Rwezaula, S., Meda, E., Mgaya, J., Lowe, B., Muturi, D., Roberts, D. J., Williams, T. N., Pallangyo, K., Kitundu, J., Fegan, G., Kirkham, F. J., Marsh, K., & Newton, C. R.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-02-16
- Volume
- 6
- Issue
- 2
- Pages
- e14699
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1999936817
- Cited by
- 326
- References
- 32
- FWCI
- 6.79
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.